Sta Pharmaceutical Co
Sta Pharmaceutical Co., also known as Sta Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Founded in the early 2000s, the company has established itself as a leader in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong operational presence across Asia and beyond, Sta Pharma focuses on innovative solutions in therapeutic areas such as oncology, cardiovascular health, and infectious diseases. Their commitment to quality and compliance has earned them a solid reputation in the global market, marked by significant milestones in regulatory approvals and partnerships. Sta Pharmaceutical Co. is recognised for its unique approach to product development, leveraging advanced technologies to enhance efficacy and safety. This dedication to excellence positions Sta Pharma as a trusted partner in the pharmaceutical landscape, contributing to improved health outcomes worldwide.
DitchCarbon Score
How does Sta Pharmaceutical Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sta Pharmaceutical Co's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sta Pharmaceutical Co's reported carbon emissions
Sta Pharmaceutical Co, headquartered in China (CN), currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data and commitments, it is unclear how Sta Pharmaceutical Co is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. As the sector increasingly focuses on sustainability, it will be important for the company to establish clear climate commitments and reduction strategies to align with global efforts in mitigating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sta Pharmaceutical Co is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
